Thrombosis associated with thrombocytopenia is an apparent paradox that is present across a wide spectrum of disorders. While thrombocytopenia has been a controversial clinical classification criterion for antiphospholipid syndrome because initial reports failed to demonstrate a relation between low platelet count with other clinical or laboratory manifestations of the syndrome, recent data highlight the association between mild to moderate thrombocytopaenia and the risk of thrombosis. Although antiphospholipid antibodies may induce platelet activation in vitro, additional stimuli may contribute to their activation in vivo, amongst which reactive oxygen and nitrogen species and lipid peroxidation products, elevated in patients with the antiphospholipid syndrome: an excess of the same stimuli may induce megakaryocyte and platelet apoptosis that leads to decreased platelet production and increased destruction, exposure resulting ultimately in thrombocytopaenia. Herein we provide a novel plausible framework involving free radicals that could add to the understanding of the thrombocytopenia/thrombosis paradox in the antiphospholipid syndrome.

Thrombocytopenia in antiphospholipid syndrome: a free radical perspective / Ames, Paul R J; Bucci, Tommaso; Merashli, Mira; Arcaro, Alessia; Gentile, Fabrizio. - In: RHEUMATOLOGY. - ISSN 1462-0332. - (2022). [10.1093/rheumatology/keac650]

Thrombocytopenia in antiphospholipid syndrome: a free radical perspective

Bucci, Tommaso;Gentile, Fabrizio
2022

Abstract

Thrombosis associated with thrombocytopenia is an apparent paradox that is present across a wide spectrum of disorders. While thrombocytopenia has been a controversial clinical classification criterion for antiphospholipid syndrome because initial reports failed to demonstrate a relation between low platelet count with other clinical or laboratory manifestations of the syndrome, recent data highlight the association between mild to moderate thrombocytopaenia and the risk of thrombosis. Although antiphospholipid antibodies may induce platelet activation in vitro, additional stimuli may contribute to their activation in vivo, amongst which reactive oxygen and nitrogen species and lipid peroxidation products, elevated in patients with the antiphospholipid syndrome: an excess of the same stimuli may induce megakaryocyte and platelet apoptosis that leads to decreased platelet production and increased destruction, exposure resulting ultimately in thrombocytopaenia. Herein we provide a novel plausible framework involving free radicals that could add to the understanding of the thrombocytopenia/thrombosis paradox in the antiphospholipid syndrome.
2022
antiphospholipid syndrome; lipid peroxidation products; reactive oxygen and nitrogen species; thrombocytopenia
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Thrombocytopenia in antiphospholipid syndrome: a free radical perspective / Ames, Paul R J; Bucci, Tommaso; Merashli, Mira; Arcaro, Alessia; Gentile, Fabrizio. - In: RHEUMATOLOGY. - ISSN 1462-0332. - (2022). [10.1093/rheumatology/keac650]
File allegati a questo prodotto
File Dimensione Formato  
Ames_Thrombocytopaenia-in-antiphospholipid_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 453.61 kB
Formato Adobe PDF
453.61 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1661599
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact